Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation

Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Kyu-won, Woo, Ok Hee, Yong, Hwan Seok, Shin, Bong Kyung, Shim, Jae Jeong, Kang, Eun-Young
Formato: Texto
Lenguaje:English
Publicado: The Korean Radiological Society 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627222/
https://www.ncbi.nlm.nih.gov/pubmed/18385565
http://dx.doi.org/10.3348/kjr.2008.9.2.175
_version_ 1782163517664657408
author Hwang, Kyu-won
Woo, Ok Hee
Yong, Hwan Seok
Shin, Bong Kyung
Shim, Jae Jeong
Kang, Eun-Young
author_facet Hwang, Kyu-won
Woo, Ok Hee
Yong, Hwan Seok
Shin, Bong Kyung
Shim, Jae Jeong
Kang, Eun-Young
author_sort Hwang, Kyu-won
collection PubMed
description Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.
format Text
id pubmed-2627222
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Korean Radiological Society
record_format MEDLINE/PubMed
spelling pubmed-26272222009-02-17 Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation Hwang, Kyu-won Woo, Ok Hee Yong, Hwan Seok Shin, Bong Kyung Shim, Jae Jeong Kang, Eun-Young Korean J Radiol Case Report Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man. The Korean Radiological Society 2008 2008-04-20 /pmc/articles/PMC2627222/ /pubmed/18385565 http://dx.doi.org/10.3348/kjr.2008.9.2.175 Text en Copyright © 2008 The Korean Radiological Society http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hwang, Kyu-won
Woo, Ok Hee
Yong, Hwan Seok
Shin, Bong Kyung
Shim, Jae Jeong
Kang, Eun-Young
Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title_full Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title_fullStr Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title_full_unstemmed Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title_short Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
title_sort reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627222/
https://www.ncbi.nlm.nih.gov/pubmed/18385565
http://dx.doi.org/10.3348/kjr.2008.9.2.175
work_keys_str_mv AT hwangkyuwon reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation
AT woookhee reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation
AT yonghwanseok reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation
AT shinbongkyung reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation
AT shimjaejeong reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation
AT kangeunyoung reversiblelansoprazoleinducedinterstitiallungdiseaseshowingimprovementafterdrugcessation

Ejemplares similares